Alligator Bioscience reports survival benefit of mitazalimab with mFOLFIRINOX - PharmaTimes Comparison shows improved survival rates for pancreatic cancer treatment

#immunotherapy #AlligatorBioscience #mitazalimab #mFOLFIRINOX #pancreaticcancer #metastaticpancreaticadenocarcinomacancer #mPDAC #mPDACpatients #OPTIMIZE1trial #metastaticpancreaticcancertreatment #healthoutcomesresearch #ASCOGastrointestinalCancersSymposium
pharmatimes.com/news/alligat...